95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-15.05%
Negative revenue growth while SA stands at 0.00%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-15.05%
Negative gross profit growth while SA is at 0.00%. Joel Greenblatt would examine cost competitiveness or demand decline.
-31.12%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-31.12%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-25.48%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
171.04%
EPS growth of 171.04% while SA is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
171.04%
Diluted EPS growth of 171.04% while SA is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-185.05%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-185.05%
Negative FCF growth while SA is at 61.94%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
35.12%
10Y CAGR of 35.12% while SA is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
35.12%
5Y CAGR of 35.12% while SA is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
15.00%
3Y CAGR of 15.00% while SA is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-224.40%
Negative 3Y OCF/share CAGR while SA stands at 73.83%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-29.74%
Negative equity/share CAGR over 10 years while SA stands at 28.77%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-29.74%
Negative 5Y equity/share growth while SA is at 28.77%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-31.50%
Negative 3Y equity/share growth while SA is at 28.77%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
32.53%
AR growth is negative/stable vs. SA's 230.77%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
17.35%
Inventory growth of 17.35% while SA is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
-13.66%
Negative asset growth while SA invests at 5.52%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-23.19%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-163.74%
We cut SG&A while SA invests at 7.92%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.